Increased risk for non-autoimmune hypothyroidism in young patients with congenital heart defects

E Passeri1, M Frigerio, T De Filippis

  • 1Endocrinology and Diabetology Unit, Dipartimento di Scienze Medico-Chirurgiche, Università degli Studi di Milano, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, 20097 San Donato Milanese, Italy. luca.persani@unimi.it

Insights

Children with congenital heart defects (CHD) have a significantly higher risk of developing congenital hypothyroidism (CH) and mild acquired hypothyroidism. Early detection and regular monitoring of thyroid function are crucial for managing these patients.

Area of Science:

  • Pediatric Endocrinology
  • Cardiology
  • Genetics

Background:

  • Newborns with congenital hypothyroidism (CH) face an elevated risk of congenital heart defects (CHD) due to shared embryonic developmental pathways.
  • The study explores the connection between thyroid disorders and CHD in pediatric patients.

Purpose of the Study:

  • To determine the prevalence and underlying causes of thyroid disorders in young patients diagnosed with CHD.
  • To investigate the relationship between thyroid dysfunction and the characteristics of congenital heart disease.

Main Methods:

  • A prospective observational study was conducted from January 2007 to January 2009.
  • 324 children (aged 0.2-15.4 years) with CHD underwent hormonal and genetic screening, including assessment of serum TSH and thyroid hormone levels.
  • Genetic analysis focused on candidate genes and microdeletions, including 22q11.2.

Main Results:

  • The prevalence of CH was 1:162 among CHD patients. Mild hypothyroidism was identified in 11.5% of children negative for CH at neonatal screening.
  • Hypothyroidism was not associated with specific CHD types, but TSH levels correlated with N-terminal pro-type B natriuretic peptide.
  • Thyroid autoimmunity was found in 8.1% of hypothyroid children, and 22q11.2 microdeletions were detected in 8.3% of CHD patients.

Conclusions:

  • Patients with CHD exhibit a 10-fold higher risk of CH and a 3-fold higher risk of acquired mild hypothyroidism.
  • Undiagnosed mild hypothyroidism can adversely impact CHD outcomes, necessitating regular thyroid function monitoring.
  • While thyroid autoimmunity and 22q11.2 microdeletions contribute to a small fraction of cases, the strong association between CHD and thyroid disorders suggests unknown underlying mechanisms.
Abstract

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...